Target expression details
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T56308 | ||||
Target Name | Interleukin-11 | ||||
Synonyms | AGIF; Adipogenesis inhibitory factor; IL-11; Oprelvekin; IL11 | ||||
Target Type | Clinical Trial | ||||
Gene Name | IL11 | ||||
Biochemical Class | Cytokine: interleukin | ||||
UniProt ID | IL11_HUMAN | ||||
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
Disease | Thrombocytopenia | ||||
Example drug | VM-501 | Phase 3 | [1], [2] | ||
Tissue | Whole blood | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: 0.06 Z-score: 0.38 P-value: 7.66E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
![]() |
|||||
Target Gene Expression Profiles in Other Tissues of Healthy Individuals | |||||
![]() |
|||||
Reference | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033052) | ||||
REF 2 | NCBI GEO: archive for functional genomics data sets--update. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.